When using cholesterol (CHO-HP) as an auxiliary emulsifier, different synthetic phospholipids can be chosen to meet the requirements of various drug components, enabling the preparation of liposomes with different characteristics.
NMPA CDE registration no.: F20180000839(A)
USFDA DMF no.: 019577
| Product Name | 1,2-Dierucoyl-sn-glycero-3-phosphocholine (for injection)DEPC |
| Chemical Name | / |
| CAS No. | 51779-95-4 |
| NMPA CDE registration no. | F20180000839 |
| USFDA DMF No. | 19577 |
| Quality grade | Injection |
| Quality standards | Manufacturer's standard |
| Molecular Formula | C52H100NO8P |
| Applications and examples | Bupivacaine liposome injection |
| Product code | S01008 |
| Package sizes | 1kg |
| Storage condition | Powder，-20°C，3 years 4°C，2 years |
Diethylpyrocarbonate (DEPC) has a well-defined structure, high purity, and stable physicochemical properties. Application: Bupivacaine Liposome Injectable Suspension.
DEPC can form stable phospholipid bilayers to encapsulate drug molecules. In general, phosphatidylcholine (PC) phospholipids are indispensable lipid molecules for preparing liposomes. Liposomes prepared with PC phospholipids as the main component exhibit better drug molecule encapsulation and dispersion in vivo.
If you have any questions, please don't hesitate to contact us. We're always here to help with Pharmaceutical Excipients for your business. We can provide products ranging from grams to tons. AVT is able to produce and even register the product in US FDA according to your special needs.
EN
jp 
ko 
fr 
es 
ru 
ms 
id 
bn 
